Search

Gary B. Nickol

Examiner (ID: 7592)

Most Active Art Unit
1642
Art Unit(s)
OPT, 1643, 1646, 1642, 1645
Total Applications
517
Issued Applications
160
Pending Applications
177
Abandoned Applications
180

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7161131 [patent_doc_number] => 20050084862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Sample preparation for the detection of infectious agents' [patent_app_type] => utility [patent_app_number] => 10/500167 [patent_app_country] => US [patent_app_date] => 2002-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3439 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084862.pdf [firstpage_image] =>[orig_patent_app_number] => 10500167 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/500167
Sample preparation for the detection of infectious agents Dec 23, 2002 Abandoned
Array ( [id] => 6856138 [patent_doc_number] => 20030129639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'GDU, a novel signalling protein' [patent_app_type] => new [patent_app_number] => 10/323001 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3174 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129639.pdf [firstpage_image] =>[orig_patent_app_number] => 10323001 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/323001
GDU, a novel signalling protein Dec 17, 2002 Abandoned
Array ( [id] => 8244767 [patent_doc_number] => 08202688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant' [patent_app_type] => utility [patent_app_number] => 10/300247 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 23010 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202688.pdf [firstpage_image] =>[orig_patent_app_number] => 10300247 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/300247
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant Nov 19, 2002 Issued
Array ( [id] => 663675 [patent_doc_number] => 07101985 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-05 [patent_title] => 'Methods and compositions in checkpoint signaling' [patent_app_type] => utility [patent_app_number] => 10/300453 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 26 [patent_no_of_words] => 34357 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101985.pdf [firstpage_image] =>[orig_patent_app_number] => 10300453 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/300453
Methods and compositions in checkpoint signaling Nov 19, 2002 Issued
60/509037 Methods for treating cancer by inhibiting Wnt signaling Oct 3, 2002 Pending
Array ( [id] => 6765589 [patent_doc_number] => 20030099988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Novel Human tumor suppressor' [patent_app_type] => new [patent_app_number] => 10/243815 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17426 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20030099988.pdf [firstpage_image] =>[orig_patent_app_number] => 10243815 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/243815
Novel Human tumor suppressor Sep 12, 2002 Abandoned
Array ( [id] => 6750314 [patent_doc_number] => 20030044834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'GDU, a novel signalling protein' [patent_app_type] => new [patent_app_number] => 10/242332 [patent_app_country] => US [patent_app_date] => 2002-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3174 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044834.pdf [firstpage_image] =>[orig_patent_app_number] => 10242332 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/242332
GDU, a novel signalling protein Sep 10, 2002 Abandoned
60/509052 Methods of modulating cell death based on the Bit-1/AES regulatory pathway Sep 5, 2002 Pending
60/509048 Collagen-binding molecules that selectively home to tumor vasculature and methods of using same Aug 27, 2002 Pending
Array ( [id] => 6861615 [patent_doc_number] => 20030092623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Bv8 nucleic acids and polypeptides with mitogenic activity' [patent_app_type] => new [patent_app_number] => 10/231411 [patent_app_country] => US [patent_app_date] => 2002-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 33191 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092623.pdf [firstpage_image] =>[orig_patent_app_number] => 10231411 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/231411
Bv8 nucleic acids and polypeptides with mitogenic activity Aug 26, 2002 Issued
Array ( [id] => 7314252 [patent_doc_number] => 20040033974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Use of genes identified to be involved in tumor development for the development of anti-cancer drugs' [patent_app_type] => new [patent_app_number] => 10/224524 [patent_app_country] => US [patent_app_date] => 2002-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6219 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033974.pdf [firstpage_image] =>[orig_patent_app_number] => 10224524 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/224524
Use of genes identified to be involved in tumor development for the development of anti-cancer drugs Aug 18, 2002 Abandoned
Array ( [id] => 7312983 [patent_doc_number] => 20040033495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators' [patent_app_type] => new [patent_app_number] => 10/211462 [patent_app_country] => US [patent_app_date] => 2002-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 145129 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033495.pdf [firstpage_image] =>[orig_patent_app_number] => 10211462 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/211462
Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators Jul 31, 2002 Abandoned
Array ( [id] => 6674281 [patent_doc_number] => 20030059884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/200617 [patent_app_country] => US [patent_app_date] => 2002-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 616 [patent_figures_cnt] => 616 [patent_no_of_words] => 61099 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20030059884.pdf [firstpage_image] =>[orig_patent_app_number] => 10200617 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/200617
Secreted and transmembrane polypeptides and nucleic acids encoding the same Jul 17, 2002 Abandoned
Array ( [id] => 6750343 [patent_doc_number] => 20030044863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Invasion complex and methods of targeting' [patent_app_type] => new [patent_app_number] => 10/197725 [patent_app_country] => US [patent_app_date] => 2002-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5897 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044863.pdf [firstpage_image] =>[orig_patent_app_number] => 10197725 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/197725
Invasion complex and methods of targeting Jul 17, 2002 Abandoned
Array ( [id] => 6783008 [patent_doc_number] => 20030064455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/198766 [patent_app_country] => US [patent_app_date] => 2002-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 616 [patent_figures_cnt] => 616 [patent_no_of_words] => 61096 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064455.pdf [firstpage_image] =>[orig_patent_app_number] => 10198766 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/198766
Secreted and transmembrane polypeptides and nucleic acids encoding the same Jul 17, 2002 Abandoned
Array ( [id] => 7362598 [patent_doc_number] => 20040005313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => ' Use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role' [patent_app_type] => new [patent_app_number] => 10/197619 [patent_app_country] => US [patent_app_date] => 2002-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7044 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005313.pdf [firstpage_image] =>[orig_patent_app_number] => 10197619 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/197619
Use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role Jul 15, 2002 Abandoned
Array ( [id] => 6846324 [patent_doc_number] => 20030165491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => '22196, a novel human aminopeptidase' [patent_app_type] => new [patent_app_number] => 10/192445 [patent_app_country] => US [patent_app_date] => 2002-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31371 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165491.pdf [firstpage_image] =>[orig_patent_app_number] => 10192445 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/192445
22196, a novel human aminopeptidase Jul 9, 2002 Abandoned
Array ( [id] => 6846323 [patent_doc_number] => 20030165490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => '22196, a novel human aminopeptidase' [patent_app_type] => new [patent_app_number] => 10/192207 [patent_app_country] => US [patent_app_date] => 2002-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31368 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165490.pdf [firstpage_image] =>[orig_patent_app_number] => 10192207 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/192207
22196, a novel human aminopeptidase Jul 9, 2002 Abandoned
Array ( [id] => 6829760 [patent_doc_number] => 20030180818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Peptidoglycan recognition proteins' [patent_app_type] => new [patent_app_number] => 10/180454 [patent_app_country] => US [patent_app_date] => 2002-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 68580 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180818.pdf [firstpage_image] =>[orig_patent_app_number] => 10180454 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/180454
Peptidoglycan recognition proteins Jun 26, 2002 Issued
Array ( [id] => 6688402 [patent_doc_number] => 20030032127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/183012 [patent_app_country] => US [patent_app_date] => 2002-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 616 [patent_figures_cnt] => 616 [patent_no_of_words] => 57321 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032127.pdf [firstpage_image] =>[orig_patent_app_number] => 10183012 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/183012
PRO1305-polypeptides Jun 25, 2002 Issued
Menu